We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.02B
AUM Growth
+$31.2M
Cap. Flow
-$130M
Cap. Flow %
-6.43%
Top 10 Hldgs %
16.17%
Holding
2,969
New
1,707
Increased
193
Reduced
681
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 12.58%
3 Industrials 10.34%
4 Healthcare 9.4%
5 Consumer Discretionary 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAGE
2801
Niagen Bioscience
NAGE
$242M
$6K ﹤0.01%
+2,230
New +$6.32K
SYRS
2802
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$6K ﹤0.01%
+37
New +$4.51K
SALM
2803
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$6K ﹤0.01%
+861
New +$5.87K
UFAB
2804
DELISTED
Unique Fabricating, Inc.
UFAB
$6K ﹤0.01%
+514
New +$6.28K
HYLD
2805
DELISTED
High Yield ETF
HYLD
$6K ﹤0.01%
195
SSI
2806
DELISTED
Stage Stores Inc
SSI
$6K ﹤0.01%
+2,464
New +$6.62K
APTI
2807
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$6K ﹤0.01%
+541
New +$7.83K
TAX
2808
DELISTED
Liberty Tax, Inc. Class A
TAX
$6K ﹤0.01%
+395
New +$5.62K
ENTL
2809
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$6K ﹤0.01%
+465
New +$7.47K
UCP
2810
DELISTED
UCP, Inc.
UCP
$6K ﹤0.01%
+630
New +$7K
PFSW
2811
DELISTED
PFSweb, Inc.
PFSW
$6K ﹤0.01%
+930
New +$7.03K
IMDZ
2812
DELISTED
Immune Design Corp.
IMDZ
$6K ﹤0.01%
+874
New +$5.05K
BBH icon
2813
VanEck Biotech ETF
BBH
$428M
$5K ﹤0.01%
50
CLSD
2814
DELISTED
Clearside Biomedical
CLSD
$5K ﹤0.01%
+39
New +$4.6K
CRVS icon
2815
Corvus Pharmaceuticals
CRVS
$1.2B
$5K ﹤0.01%
+259
New +$4.06K
EZM icon
2816
WisdomTree US MidCap Fund
EZM
$956M
$5K ﹤0.01%
151
+1
+0.7% +$35
GCBC icon
2817
Greene County Bancorp
GCBC
$587M
$5K ﹤0.01%
+470
New +$5.28K
GVI icon
2818
iShares Intermediate Government/Credit Bond ETF
GVI
$3.79B
$5K ﹤0.01%
52
IBRX icon
2819
ImmunityBio
IBRX
$8.05B
$5K ﹤0.01%
+1,305
New +$6.45K
IMUX icon
2820
Immunic
IMUX
$196M
$5K ﹤0.01%
+3
New +$5.49K
LPCN icon
2821
Lipocine
LPCN
$17.5M
$5K ﹤0.01%
+76
New +$4.93K
QCLN icon
2822
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$627M
$5K ﹤0.01%
330
HIND
2823
Vyome Holdings
HIND
$15.7M
0
SHV icon
2824
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
$5K ﹤0.01%
50
SLYV icon
2825
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.07B
$5K ﹤0.01%
100

Similar funds

Ameritas Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Ameritas Investment Partners held 2,969 positions worth $2.02B, up 1.6% from $1.99B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameritas Investment Partners withdrew a net $130M in Q1 2017, closing 23 positions and reducing 681 holdings. Its most notable exit was Vanguard Total Bond Market, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Bioverativ Inc. Common Stock worth $2.4M.

  • Ameritas Investment Partners's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 44,128 shares worth $2.4M.
  • Ameritas Investment Partners added most to State Street Health Care Select Sector SPDR ETF in Q1 2017, an estimated $2.78M increase.
  • Ameritas Investment Partners's biggest Q1 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $61.8M.
  • Ameritas Investment Partners fully exited Vanguard Total Bond Market in Q1 2017, selling an estimated $34M.
  • Ameritas Investment Partners's ten largest holdings make up 16% of its $2.02B portfolio in Q1 2017.
  • Ameritas Investment Partners opened 1,707 new positions and closed 23 in Q1 2017.
  • Ameritas Investment Partners's portfolio value rose 1.6% quarter-over-quarter to $2.02B.

Based on Ameritas Investment Partners's 13F filing for Q1 2017, filed 9 May 2017.